[Peter]

#1018324

The 2010 Graves’ Disease Foundation’s Patient & Family Conference "Early Bird" discount has been extended to September 29th – SAVE $50! Join us the weekend of October 22-24 in beautiful San Diego, California at the Bahia Resort hotel on the beach.

Conference Registration – $175 – includes meals & receptions.SIGN UP NOW … get the Bahia Resort Hotel special rate too – only $99 a night! To register go to http://www.NGDF.org and click Conference, print & fax the registration form, or call the National Office – 877.643.3123.

This year’s meeting will have the largest number of physicians and researchers ever! You will meet 8 world-renowned doctors who will give you the latest update on research for thyroid disease and eye involvement. Plus learn from Endocrinologists who will inform you about diagnosis and treatment options. There will be separate small group sessions for patients and family plus interesting topics like Graves’ disease and children.

Dr. Terry Smith, GDF Chief Medical. & Scientific Officer announces these Speakers:

Andrew Gianoukakis, M.D.
Associate Professor of Medicine, UCLA School of Medicine and Director of Endocrine Clinic, Division of Endocrinology & Metabolism at Harbor-UCLA Medical.

His special interest focuses on autoimmune thyroid disease and thyroid cancer. His research concerns the pathogenesis of Graves’ disease. Dr. Gianoukakis has developed a primary thyroid epithelial cell culture model and has used this to identify important mediators of the inflammatory responses seen in Graves’ disease. The clinical significance of these findings is currently being examined in a clinical research study. The ultimate goal for this line of investigation is to identify molecular targets through which the disease process can be interrupted.

Raymond S. Douglas, M.D., Ph.D.
Eye Plastic, Orbital and Facial Cosmetic Surgery
Associate Professor, Ophthalmology and Visual Sciences
University of Michigan
Kellogg Eye Center – Ann Arbor, MI

Specialty Interests:
Orbital surgery, especially minimally invasive surgery, and decompressions for thyroid-associated eye disease. Cosmetic facial surgery including blepharoplasty, eyelid lift, midface lift, fillers for under-eye hollows and Botox injections. Post-cancer reconstruction including Mohs surgery.

Don O. Kikkawa, M.D.
Professor of Clinical Ophthalmology, Chief of Division of Ophthalmic Plastic and Reconstructive Surgery
University of California, San Diego
Shiley Eye Center – La Jolla, CA
Specialty Interests:

Don O. Kikkawa, M.D., serves as Chief, Division of Ophthalmic Plastic and Reconstructive Surgery. Esteemed for his knowledge, surgical skill and personable style, Dr. Kikkawa continues to speak and teach to other physicians around the world. In 1997, he was selected to serve as Guest Editor of the International Ophthalmology Clinics monograph on "Aesthetic Ophthalmic Plastic Surgery." He is a recipient of the "Most Outstanding Publication" in 1995 awarded by the American Society of Ophthalmic Plastic and Reconstructive Surgery for his co-authorship on orbital and eyelid anatomy.

Anca M. Avram, M.D. of the University of Michigan
Specialty: Nuclear Medicine
Clinical Interests:

Radioactive Iodine treatment for Thyroid Cancer and Hyperthyroidism; Radioimmunotherapy in Lymphoma; Neuroendocrine Tumors; Multiple Endocrine Neoplasia Syndromes; and Pheochromocytoma. Dr. Avram’s research interests center on Radionuclide therapy for Non-Hodgkin Lymphoma (NHL) and Thyroid Cancer, Quantitative I-131 imaging for accurate internal dose estimation in radioimmunotherapy for NHL.

Mark J. Lucarelli, M.D., FACS
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Mark Lucarelli specializes in ophthalmic plastic surgery (oculoplastics). This area includes eyelid surgery, brow lift, lacrimal surgery, orbital surgery, thryoid eye disease, fillers and Botox, and other facial procedures. Dr. Mark Lucarelli is fellowship trained and is certified by the American Board of Ophthalmology. He is considered a leader in the field of ophthalmic plastic surgery.

Kimberly Cockerham, M.D.
Adjunct Clinical Associate Professor, Dept. of Ophthalmology
Stanford University School
Dr. Kim Cockerham actively keeps current in plastics, orbit, and neuro-ophthalmology. A passionate educator as well as practitioner, she is the co-director of the annual Bay Area Ophthalmology course at Stanford. Dr. Cockerham’s areas of interest include: eyelid and facial rejuvenation, thyroid eye disease, eyelid oncology, double vision and decreased vision due to optic nerve dysfunction.

Here’s a partial list of topics for the General Sessions:
– Diagnosis and Treatment of Graves’ Hyperthyroidism
– New Biological therapies for Graves’ disease and Ophthalmopathy
– Pros & cons of long term medical management of Graves’ disease
– Is RAI contra-indicated in patients with Graves’ Ophthalmopathy?

[Ski]

#1064020

If you’re on the fence about attending, please know that these are informative and helpful for patients at every stage of treatment ~ you will be glad you joined us!

[Author]

Posts